Neurogenic Bladder
📧 Sign up to get email alerts when something new happens for Neurogenic Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: PK/PD, Long-term Safety and Efficacy of Tamsulosin Treatment in Children With Neurogenic Bladder [Phase 2]
This update reports Phase 2 results on the pharmacokinetics, pharmacodynamics, long-term safety, and efficacy of tamsulosin in children with…
-
CLINICAL_TRIALS trial_result · 2015-04-17Clinical Trial Update: Treatment of Neurogenic Incontinence by Surgery to Cut the Filum Terminale
This clinical trial examining surgical cutting of the filum terminale to treat neurogenic bladder dysfunction and dysfunctional voiding has …
-
CLINICAL_TRIALS trial_result · 2014-11-03Clinical Trial Update: Multifaceted Treatment of Catheter-related Urinary Tract Infection [Phase 2]
Phase 2 clinical trial update on multifaceted treatment for catheter-related urinary tract infection in patients with spinal cord injury and…
-
FDA approval · 2014-07-18FDA Approved: OXYTROL — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for OXYTROL (oxybutynin) from Allergan, Inc.
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Quality of Life Intermittent Catheter Study [Phase 4]
Coloplast A/S completed a Phase 4 trial assessing quality of life with intermittent catheterization for neurogenic bladder dysfunction; resu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-02-11Clinical Trial Update: Urinary and Sexual Function Before and After Surgical Decompression of Cervical Myelopathy
This clinical trial examines urinary and sexual function before and after surgical decompression for cervical myelopathy.
-
CLINICAL_TRIALS trial_result · 2014-01-24Clinical Trial Update: Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder [Phase 3]
A Phase 3 safety and efficacy trial of botulinum toxin type A for neurogenic overactive bladder was terminated, with results posted in Janua…
-
FDA approval · 2013-08-30FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for oxybutynin chloride submitted by Chartwell RX, LLC.
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Comparing Urinary Tract Infections in Children With Spina Bifida Using Two Types of Catheters for Catheterization [NA]
This Clinical Trial Update compares two catheter types for catheterization in children with Spina bifida and neurogenic bladder, focusing on…
-
CLINICAL_TRIALS trial_result · 2012-10-30Clinical Trial Update: Botox Versus Oxybutynin as First Line Treatment for the Poorly Compliant Pediatric Neurogenic Bladder [Phase 3]
A Phase 3 trial comparing Botox (onabotulinumtoxinA) to oxybutynin as first-line treatment for poorly compliant pediatric neurogenic bladder…
-
CLINICAL_TRIALS trial_result · 2012-10-05Clinical Trial Update: Efficacy and Safety of Silodosin on Voiding Dysfunction Associated With Neurogenic Bladder [Phase 4]
Phase 4 clinical trial update assessing the efficacy and safety of silodosin for voiding dysfunction associated with neurogenic bladder.
-
CLINICAL_TRIALS trial_result · 2012-09-18Clinical Trial Update: Self Management in Urinary Catheter Users [Phase 2]
This is a Phase 2 trial update from the University of Rochester on self-management for people with urinary catheters, addressing urinary ret…
-
CLINICAL_TRIALS trial_result · 2012-09-12Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder [Phase 2, Phase 3]
This is a completed Phase 2/3 trial evaluating the efficacy and safety of tamsulosin in children with neurogenic bladder, with results poste…
-
CLINICAL_TRIALS research · 2012-06-14Clinical Trial Update: Medico-economical Impact of the Brindley Neurosurgical Technique in France [NA]
A completed clinical trial study assessing the economic impact of the Brindley neurosurgical technique for spinal cord injury-related condit…
-
CLINICAL_TRIALS trial_result · 2011-09-05Clinical Trial Update: Bioavailability of Vagantin® Coated Tablets Relative to an Oral Methantheline Bromide Solution [Phase 1]
Phase 1 pharmacokinetic study comparing the bioavailability of Vagantin-coated tablets with a methantheline bromide solution in neurogenic b…
-
CLINICAL_TRIALS trial_result · 2011-02-08Clinical Trial Update: Alfuzosin Treatment in Children and Adolescents With Neurogenic Urinary Bladder Dysfunction [Phase 3]
Phase 3 trial of alfuzosin in children and adolescents with neurogenic bladder dysfunction completed with results posted.
-
CLINICAL_TRIALS trial_result · 2011-02-08Clinical Trial Update: Alfuzosin Treatment in Children and Adolescents With Hydronephrosis of Neuropathic Etiology [Phase 3]
Phase 3 trial evaluating alfuzosin in children and adolescents with hydronephrosis of neurogenic etiology completed; results were posted in …
-
CLINICAL_TRIALS trial_result · 2011-02-03Clinical Trial Update: Study of Autologous Neo-Bladder Construct in Subjects With Neurogenic Bladder Following Spinal Cord Injury [Phase 2]
Phase 2 study of an autologous Neo-Bladder construct in subjects with neurogenic bladder due to spinal cord injury; study terminated with re…
-
CLINICAL_TRIALS trial_result · 2010-06-07Clinical Trial Update: Augmentation Cystoplasty Using an Autologous Neo-Bladder [Phase 2]
Phase 2 study of augmentation cystoplasty using an autologous neo-bladder in neurogenic bladder was terminated; results were posted on 2010-…
-
FDA approval · 2010-03-09FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for oxybutynin chloride from Teva Pharmaceuticals USA, updating the product labeling.
-
CLINICAL_TRIALS trial_result · 2009-12-15Clinical Trial Update: Pharmacokinetics and Safety Study With Alfuzosin in Children and Adolescents With Elevated Detrusor Leak Point Pressure of Neuropathic Etiology [Phase 3]
A Phase 3 pharmacokinetics and safety study of Alfuzosin in children and adolescents with neurogenic bladder due to neuropathic etiology.
-
CLINICAL_TRIALS research · 2009-02-20Clinical Trial Update: Effect of Botulinum Toxin in Neurogenic Bladders in Children With Myelomeningocele [Phase 4]
Phase 4 clinical trial update evaluating botulinum toxin for neurogenic bladder in children with myelomeningocele.
-
FDA approval · 2009-01-06FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved Upsher-Smith Laboratories' supplemental application for oxybutynin chloride. This action confirms approval of changes to the ge…
-
CLINICAL_TRIALS other · 2008-01-29Clinical Trial Update: Effect of Tamsulosin vs Prazosin in Treatment of Female Voiding Dysfunction [Phase 1, Phase 2]
Clinical trial update comparing tamsulosin and prazosin for female voiding dysfunction in neurogenic bladder across Phase 1 and Phase 2; sta…
-
FDA approval · 2007-02-01FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for oxybutynin chloride (Strides Pharma Science Limited) under ANDA075079. This action authorizes th…